Azurity Pharmaceuticals, Inc.
Records under this name other than the patents Azurity Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 122 patents it holds.
Showing 1 to 8 of 8 · Back to Azurity Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,128,083 | Lisinopril Formulations Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,033,498 | Solid Oral Sulfate Salt Formulations for Cleaning a Colon and Methods of Using Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,364,230 | Amlodipine Formulations Formerly held In force · High confidence | In force | High confidence | |
| US 11,918,684 | Pharmaceutical Composition of Oral Suspension of Immunosuppressive Agents Formerly held In force · High confidence | In force | High confidence | |
| US 12,042,539 | Compositions and Kits for Omeprazole Suspension Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,013,702 | Midodrine Hydrochloride Oral Solution and Uses Thereof Lapsed on the fee record Ended May 25, 2025 · High confidence | Lapsed on the fee record | Ended May 25, 2025 | High confidence |
| US 12,357,627 | Pharmaceutical Compositions of Cabozantinib Term ended Term ended Oct 19, 2024 · Low confidence | Term ended | Term ended Oct 19, 2024 | Low confidence |
| US 6,946,149 | Salt Solution for Colon Cleansing Term ended Term ended Mar 7, 2023 · High confidence | Term ended | Term ended Mar 7, 2023 | High confidence |